Related Experiment Video
Updated: Dec 5, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy
Joon Hwa Hong1, Anita Nguyen2, Hartzell Vernon Schaff2
1Cardiovascular Surgery, Heart Research Institute, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Insights
Septal myectomy effectively treats obstructive hypertrophic cardiomyopathy. Mitral valve intervention during this surgery is rarely needed unless intrinsic valve disease is present.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Cardiac Anatomy
Background:
- Obstructive hypertrophic cardiomyopathy (oHCM) is a significant cause of morbidity.
- Septal myectomy is the established surgical treatment for symptomatic oHCM unresponsive to medical therapy.
- Controversy exists regarding the need for concurrent mitral valve intervention during septal myectomy.
Purpose of the Study:
- To review the role and necessity of mitral valve intervention in patients undergoing septal myectomy for oHCM.
- To discuss anatomical considerations, imaging techniques, and surgical strategies for mitral valve management in oHCM.
Main Methods:
- Review of surgical outcomes and clinical experience at Mayo Clinic with over 3000 septal myectomy procedures.
- Analysis of anatomical factors influencing mitral valve function in oHCM.
- Evaluation of imaging modalities for assessing mitral valve pathology in oHCM.
Main Results:
- Septal myectomy reliably alleviates left ventricular outflow tract obstruction, systolic anterior motion of the mitral valve, and associated regurgitation.
- Mitral valve operation is infrequently required in patients without intrinsic mitral valve disease (e.g., leaflet prolapse, severe calcific stenosis).
- Mayo Clinic's extensive experience suggests a conservative approach to mitral valve intervention during myectomy is often appropriate.
Conclusions:
- Septal myectomy is a highly effective treatment for obstructive hypertrophic cardiomyopathy.
- Routine mitral valve intervention is not necessary in all patients undergoing septal myectomy.
- Careful patient selection and assessment for intrinsic mitral valve disease are crucial for guiding surgical decisions.
Abstract:
Septal myectomy is the gold standard treatment option for patients with obstructive hypertrophic cardiomyopathy whose symptoms do not respond to medical therapy. This operation reliably relieves left ventricular outflow tract gradients, systolic anterior motion of the mitral valve, and associated mitral valve regurgitation. However, there remains controversy regarding the necessity of mitral valve intervention at the time of septal myectomy. While some clinicians advocate for concomitant mitral valve procedures, others strongly believe that the mitral valve should only be operated on if there is intrinsic mitral valve disease. At Mayo Clinic, we have performed septal myectomy on more than 3000 patients with obstructive hypertrophic cardiomyopathy, and in our experience, mitral valve operation is rarely necessary for patients who do not have intrinsic mitral valve disease such as leaflet prolapse or severe calcific stenosis. In this paper, we review anatomical considerations, imaging, and surgical approaches in the management of the mitral valve in hypertrophic cardiomyopathy.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis IV: Nursing Management

